←
JTCancerCenter5,593 posts
JTCancerCenter avatar

JTCancerCenter

@JTCancerCenter

John Theurer Cancer Center @HackensackUMC is among the nation's top cancer hospitals with 14 specialized divisions providing the most advanced care possible.

◷ Joined September 2009▧ 1,040 Photos and videos
OncLive.com avatar
⟳ JTCancerCenter retweeted
OncLive.com@OncLive·Sep 3

📰 GLP-1s are generating significant buzz for their metabolic benefits, as well as for their potential to directly combat breast cancer progression. #bcsm #oncology Read insights from Deena Graham, MD, of @JTCancerCenter and @HMHNewJersey here: onclive.com/view/a-new-playe…

OncLive.com avatar
⟳ JTCancerCenter retweeted
OncLive.com@OncLive·Jul 9

🎥On this video podcast episode of #OncLiveOnAir, @BiranNoa of @JTCancerCenter broke down key multiple myeloma data shared at the 2026 @ASCO Annual Meeting. Watch here ➡️: onclive.com/view/unpacking-k… #mmsm #oncology

Miguel Gonzalez Velez, MD avatar
⟳ JTCancerCenter retweeted
Miguel Gonzalez Velez, MD@mgonzalezvelMD·Jul 1

@JTCancerCenter opening first-in-human trial of ML261, a potency-enhanced anti-DLL3 CAR T therapy, in relapsed SCLC and NEC. Advancing cellular therapies in solids. @ADesaiMD @salmanpunekar #LCSM #SCLC sprou.tt/1MBEdt2E1rS

OncLive.com avatar
⟳ JTCancerCenter retweeted
OncLive.com@OncLive·Jan 25

👀 Robotic surgery, transvesical approaches, and the single-port era, were all topics covered by @RoboticsUrology of @JTCancerCenter in his commentary on paradigm shifts in minimally invasive surgeries. Full details here 🤖: hubs.li/Q040d3MB0 #pcsm #oncology

Georgetown Cancer Prevention and Control Program avatar
⟳ JTCancerCenter retweeted
Georgetown Cancer Prevention and Control Program@GeorgetownCPC·Jan 21

"[Patients] with #LungCancer are often met with accusations, said @drCarterBawa [of] @HMHNewJersey. The first question that anybody asks is, 'Did you smoke?' she said." @nytimes highlighting @drCarterBawa's incredible #LungCancer stigma work! Read more 👇 nytimes.com/2026/01/14/well/…

CURE Today avatar
⟳ JTCancerCenter retweeted
CURE Today@cure_today·Jan 17

🩺 The Three Pillars of #PancreasCancer Treatment Dr. Benjamin Jon Golas, of @JTCancerCenter, breaks down how surgery, chemo, and radiation form the foundation of curative-intent therapy for pancreas cancer. Learn more and wathc the whole video here! hubs.li/Q03_0mQK0

OncLive.com avatar
⟳ JTCancerCenter retweeted
OncLive.com@OncLive·9 Dec 2025

WATCH: Lori A. Leslie, MD, discusses 3-year efficacy findings with epcoritamab plus rituximab and lenalidomide in previously untreated follicular lymphoma. @LoriLeslieMD @JTCancerCenter @HackensackUMC @ASH_hematology #ASH25 #lymsm #hematology onclive.com/view/dr-leslie-o…

Lymphoma Hub avatar
⟳ JTCancerCenter retweeted
Lymphoma Hub@lymphomahub·7 Dec 2025

CONGRESS | #ASH25 | PRESENTATION Lori Leslie shares 3-year results from the phase Ib/II EPCORE NHL-2 trial, of 1L epcoritamab with rituximab + lenalidomide (Arm 6; n = 41) and epcoritamab maintenance monotherapy following SOC (Arm 7; n = 19), in patients with FL. The ORR with epcoritamab + rituximab + lenalidomide in Arm 6 was 95% and the CR rate was 88%. In Arm 7, 100% of patients with PR from last line of therapy (n = 8) achieved CR after a median of 2.8 months (range, 2.5–5.7). No new safety signals were observed in either arm; the majority of TEAEs were infectious in nature. Data indicate favorable safety and efficacy of epcoritamab, in combination with rituximab in 1L and as maintenance monotherapy, in FL. Follow our live feed for more updates: loom.ly/POS6cqk Intended for HCPs only. This congress coverage is independently supported by pharmaceutical companies, who are allowed no influence on the content; a full list of supporters can be found on our website. #lymphoma #lymsm #MedEd #MedicalCongress @LoriLeslieMD @HMHNewJersey

Post attachmentPost attachmentPost attachmentPost attachment
Lisa Marie Falbo avatar
⟳ JTCancerCenter retweeted
Lisa Marie Falbo@LisaMarieFalbo·31 Oct 2025

📺 Watch “Your New Jersey” Saturdays at 6 AM and Sundays at 8 AM on MeTV WJLP New Jersey/New York! This weekend: 1️⃣ Lindsay Colameo Peragallo, Founder of Beauty Holiday and & Lauren Encarnacion, Project Coordinator at @HMHNewJersey John Theurer Cancer Center, sharing how their collaboration brings self-care packages to patients undergoing treatment💄 
2️⃣ Lauren D’Amelio, Founder of D’Amelio Cosmetics & Nicolette Dalessandro, Celebrity Makeup Artist discuss empowering artists, running high-profile events, and giving back through their work✨ For more information, visit UpdateNewJersey.com #TV #Television #YourNewJersey #UpdateNewJersey #MeTV #WJLP #NewJersey #NJ #Watch #Local #Community #GivingBack #BeautyIndustry #SelfCare #Inspiration #LocalLife

Post attachmentPost attachmentPost attachment
Appendix Cancer PMP Research Foundation avatar
⟳ JTCancerCenter retweeted
Appendix Cancer PMP Research Foundation@acpmpresearch·29 Oct 2025

Eating well during cancer treatment can be challenging. In this interview with CURE, registered dietitian Kanisha Parikh from John Theurer Cancer Center shares practical tips for maintaining nutrition when eating becomes difficult. curetoday.com/view/eating-ti… @HMHNewJersey

CURE Today avatar
⟳ JTCancerCenter retweeted
CURE Today@cure_today·1 Oct 2025

🥗 Safe food matters, especially for immunocompromised patients with #Cancer! Dietitian Heather Ann Yonker, of @JTCancerCenter, shares step-by-step tips for handling, cooking, and storing poultry safely at home. Learn more from CURE! 👇 hubs.li/Q03LK4Nr0